)
)
Vericel Investor Relations Material
Latest events
Q3 2024
Vericel
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Vericel Corporation
Access all reports
Vericel Corporation is a biopharmaceutical company focused on developing and manufacturing advanced cell therapies for patients with severe diseases and injuries. The company’s products include autologous cell therapies used in the treatment of cartilage defects, burns, and other medical conditions. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Vericel Corporation
Q1 2024
Vericel Corporation
Q3 2024
Vericel Corporation
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
VCEL
Country
🇺🇸 United States